Factors | Overall survival | ||
---|---|---|---|
 | Hazard ratio | 95% CI a | p-value |
pTNM | Â | Â | Â |
   Stage I | 1.00 | - |  |
   Stage II | 2.05 | 1.07–3.94 | 0.03 |
   Stage III | 8.09 | 4.24–15.43 | <0.001 |
ER status | Â | Â | Â |
   Negative | 1.00 | - |  |
   Positive | 0.57 | 0.40–0.82 | 0.002 |
Factors | Disease-free survival | ||
 | Hazard ratio | 95% CI a | p-value |
pTNM | Â | Â | Â |
   Stage I | 1.00 | - |  |
   Stage II | 1.87 | 1.12–3.11 | 0.017 |
   Stage III | 3.72 | 1.59–8.70 | 0.002 |
pN | Â | Â | Â |
   pN0 | 1.00 |  |  |
   pN1 | 1.49 | 1.01–2.20 | 0.044 |
   pN2 | 2.47 | 1.14–5.34 | 0.022 |
   pN3 | 1.91 | 0.83–4.39 | 0.129 |